Chickenpox, pregnancy and the newborn

Drug and Therapeutics Bulletin

Volumn 43, Issue 9, 2005, Pages 69-71

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIHISTAMINIC AGENT; CALAMINE; CHICKENPOX VACCINE; CHLORPHENIRAMINE; HERPES ZOSTER IMMUNOGLOBULIN; IBUPROFEN; PARACETAMOL;

ARTICLE; CHICKENPOX; CHILDBIRTH; DISEASE SEVERITY; FATALITY; HUMAN; MATERNAL DISEASE; MORTALITY; NEWBORN; NEWBORN PERIOD; PREGNANCY; PREGNANT WOMAN; RISK ASSESSMENT; UNITED KINGDOM;

EID: 24944475715     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2005.43969     Document Type: Article

References (33)

1. Fairley CK, Miller E. Varicella-zoster virus epidemiology - a changing scene? J Infect Dis 1996; 174 (suppl 3): S314-9.
2. Rawson H et al. Deaths from chickenpox in England and Wales 1995-7: analysis of routine mortality data. BMJ 2001; 323: 1091-3.
3. Brisson M, Edmunds WJ. Epidemiology of varicella-zoster virus in England and Wales. J Med Virol 2003; 70: S9-14.
4. Department of Health, 2004. Varicella [online]. Available: http.://www.dh.gov.uk/assetRoot/04/07/31/40/04073140.pdf [Accessed 18 August 2005].
5. Kudesia G et al. Changes in age related seroprevalence of antibody to varicella zoster virus: impact on vaccine strategy. J Clin Pathol 2002; 55: 154-5.
6. Lee BW. Review of varicella zoster seroepidemiology in India and South-east Asia. Trop Med Int Health 1998; 3: 886-90.
7. Nathwani D et al. Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36 (suppl 1): 59-71.
8. Sissons JG. Herpesvinuses (excluding Epstein-Barr virus). In: Warrell DA et al. (Eds). Oxford Textbook of Medicine. Fourth edition. Volume 1: Sections 1-10. Oxford: Oxford University Press, 2003.
9. Royal College of Obstetricians and Gynaecologists, 2001. Chickenpox in pregnancy [online]. Available: http://www.rcog.org.uk/resources/Public/pdf/Chickenpox_No13.pdf [Accessed 18 August 2005).
10. Harger JH et al. Risk factors and outcome of varicella-zoster virus pneumonia in pregnant women. J Infect Dis 2002; 185: 422-7.
11. Heuchan A-M, Isaacs D. The management of varicella-zoster virus exposure and infection in pregnancy and the newborn period. Med J Aust 2001 174: 288-92.
12. Enders G et al. Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases. Lancet 1994; 343: 1548-51.
13. Hinshaw K, Fayyad A, 2000. The management of early pregnancy loss - (25) Oct 2000 [online]. Available: http://www.rcog.org.uk/printindex.asp?PageID=515 [Accessed 18 August 2005].
14. Office for National Statistics 2005. Deaths 2001: Childhood, infant and perinatal mortality: stillbirths, infant deaths and childhood deaths under 15 (rates) [online]. Available: http://www.statistics.gov.uk/STATBASE/xsdataset.asp?%20%20%2OMore= Y&vlnk=6667&All=Y&B2.x=24&B2.y=11 [Accessed 18 August 2005].
15. Birthistle K, Carrington D. Fetal varicella syndrome - a reappraisal of the literature. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. J Infect 1998; 36 (suppl 1): 25-9.
16. Scharf A et al. Virus detection in the fetal tissue of a premature delivery with a congenital varicella syndrome. - A case report. J Perinat Med 1990; 18: 317-22.
17. Pastuszak AL et al. Outcome after maternal varicella infection in the first 20 weeks of pregnancy. N Engl J Med 1994; 330: 901-5.
18. Tan MP, Koren G. Chickenpox in pregnancy: revisited. Repod Toxicol 2005 Jun 22; [Epub ahead of print].
19. Miller E et al. Outcome in newborn babies given anti-varicella-zoster immunoglobulin after perinatal maternal infection with varicella-zoster virus. Lancet 1989; 2 (8659): 371-3.
20. Linder N et al. Placental transfer and decay of varicella-zoster virus antibodies in preterm infants. J Pediatr 2000; 137: 85-9.
21. Hanngren KA et al. Effect of zoster immunoglobulin for varicella prophylaxis in the newborn. Scand J Infect Dis 1985; 17: 343-7.
22. Morgan-Capner P et al. Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). Commun Dis Public Health 2002; 5: 59-71.
23. Enders G. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test. Postgrad Med J 1985; 61 (suppl 4): 23-30.
24. Health Protection Agency, 2004. Immunoglobulin Handbook. Indications and dosage for normal and specific immunoglobulin preparations issued by the Health Protection Agency [online]. Available: http://www.hpa.org.uk/infections/topics_az/immunoglobulin/pdfs/ ig_handbook120704.pdf [Accessed 18 August 2005].
25. Shields KE et al. Varicella vaccine exposure during pregnancy: data from the first 5 years of the pregnancy registry. Obstet Gynecol 2001; 98: 14-9.
26. Kustermann A et al. Prenatal diagnosis of congenital varicella infection. Prenat Diagn 1996; 16: 71-4.
27. Mouly F et al. Prenatal diagnosis of fetal varicella-zoster virus infection with polymerase chain reaction of amniotic fluid in 107 cases. Am J Obstet Gynecol 1997; 177: 894-8.
28. Prodigy, 2004. Chickenpox [online]. Available from: www.prodigy.nhs.uK/guidance.asp?gt=Chickenpox [Accessed 18 August 2005].
29. Oral antihistamines for allergic disorders. DTB 2002; 40: 59-62.
30. Asano Y et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 1993; 92: 219-22.
31. Balfour Jr HH et al. Acyclovir treatment of varicella in otherwise healthy adolescents. J Pediatr 1992; 120: 627-33.
32. Andrews EB et al. Acyclovir in pregnancy registry: six years' experience. Obstet Gynecol 1992; 79: 7-13.
33. Reynolds L et al. Neonatal varicella: varicella zoster immunoglobulin (VZIG) does not prevent disease. Arch Dis Child Fetal Neonatal Ed 1999; 81: F69-70.